Stifel Nicolaus began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS - Free Report) in a report released on Monday, Marketbeat.com reports. The firm issued a buy rating and a $28.00 target price on the stock.
Kestra Medical Technologies Price Performance
Shares of KMTS stock traded down $0.73 on Monday, hitting $23.29. 62,011 shares of the stock traded hands, compared to its average volume of 275,704. Kestra Medical Technologies has a twelve month low of $20.00 and a twelve month high of $26.06.
Kestra Medical Technologies Company Profile
(
Get Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
See Also
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
